Clinical Trials

Ingenol mebutate in actinic keratosis: The PEP005-014 study

Peplin to start phase III under SPA agreement with FDA

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here